Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Translational Lung Cancer Research|January 23, 2016
Shedding light on the molecular determinants of response to anti-PD-1 therapyRoss A SooMed (New York, N.Y.)|March 14, 2026
When EGFR meets MET: Dual blockade as the next post-TKI standard?Zhaohui Liao Arter, Ross A SooTherapeutic Advances in Medical Oncology|July 17, 2020
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategiesRobert J Walsh, Ross A SooDrug Design, Development and Therapy|October 29, 2015
Dacomitinib in lung cancer: a "lost generation" EGFR tyrosine-kinase inhibitor from a bygone era?Sai-Hong Ignatius Ou, Ross A SooTherapeutic Advances in Respiratory Disease|August 3, 2016
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidenceJoline S J Lim, Ross A SooExpert Review of Anticancer Therapy|March 19, 2020
Lorlatinib for the treatment of ALK-positive metastatic non-small cell lung cancerJoan Rou-En Choo, Ross A SooTuberculosis and Respiratory Diseases|April 8, 2025
Integration of Liquid Biopsy for Optimal Management of NSCLCYuko Oya, Ichidai Tanaka, Ross A SooCurrent Drug Targets|March 31, 2012
Systemic therapies for pancreatic cancer--the role of pharmacogeneticsRoss A Soo, Wei-Peng Yong, Federico InnocentiRespirology (Carlton, Vic.)|February 18, 2015
Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)Nesaretnam Barr Kumarakulasinghe, Nico van Zanwijk, Ross A SooLung Cancer (Amsterdam, Netherlands)|June 20, 2017
Treatment options for EGFR mutant NSCLC with CNS involvement-Can patients BLOOM with the use of next generation EGFR TKIs?Chee-Seng Tan, Byoung Chul Cho, Ross A SooPageof 16